Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NEXTGEN HEALTHCARE, INC.NXGN · Entity 108396 | Director · President and CEO | November 09, 2023 | November 13, 2023 |
| STREAMLINE HEALTH SOLUTIONS INC.STRM · Entity 76542 | Director · President & CEO | June 17, 2019 | June 19, 2019 |
| Teladoc Health, Inc.TDOC · Entity 1547 | Chief Operating Officer | July 29, 2021 | August 02, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NEXTGEN HEALTHCARE, INC.
Report date November 09, 2023 · Filed November 13, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2023-11-09 transaction · row 1
1 source rowRow 1 · 2023-11-09 · Disposition to issuer · Disposed 605,540 · Balance 0 F1: Includes 295,300 outstanding unvested shares of restricted stock. F2: Pursuant to the Agreement and Plan of Merger, dated September 5, 2023, by and among the Issuer, Next Holdco Co., LLC ("Next Holdco") and Next Merger Sub, Inc. ("Merger Sub"), the Issuer became a wholly owned subsidiary of Next Holdco upon consummation of the merger with Merger Sub on November 9, 2023 (the "Effective Time"). At the Effective Time: (a) each of the Issuer's outstanding shares of common stock, each outstanding restricted stock unit and each outstanding deferred stock unit was cancelled and automatically converted into the right to receive $23.95 in cash; (b) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was cancelled and converted into the right to receive $23.95 in cash less the applicable per share exercise price; and (c) each of the Issuer's outstanding performance stock units was cancelled and converted into the right to receive $23.95 F3: (Continued from footnote 2) (with respect to the Issuer shares underlying the portion of such award which had vested), and, with respect to any portion of such award the vesting of which remained subject to achievement of performance objectives as of October 4, 2023, $23.95 for each Issuer share underlying the portion of the award that would vest as a result of the Merger in accordance with the terms and conditions of the applicable award agreement, which for the units granted in 2020 assumed performance achievement at the "maximum" level; for the units granted in 2021, assumed performance achievement above "target" with partial achievement of the next stock price hurdle; and for the units granted in 2022, assumed performance achievement at 140% of the "target" level. |
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2023-11-09 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-11-09 · Disposition to issuer · Disposed 381,059 · Balance 0 F2: Pursuant to the Agreement and Plan of Merger, dated September 5, 2023, by and among the Issuer, Next Holdco Co., LLC ("Next Holdco") and Next Merger Sub, Inc. ("Merger Sub"), the Issuer became a wholly owned subsidiary of Next Holdco upon consummation of the merger with Merger Sub on November 9, 2023 (the "Effective Time"). At the Effective Time: (a) each of the Issuer's outstanding shares of common stock, each outstanding restricted stock unit and each outstanding deferred stock unit was cancelled and automatically converted into the right to receive $23.95 in cash; (b) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was cancelled and converted into the right to receive $23.95 in cash less the applicable per share exercise price; and (c) each of the Issuer's outstanding performance stock units was cancelled and converted into the right to receive $23.95 F3: (Continued from footnote 2) (with respect to the Issuer shares underlying the portion of such award which had vested), and, with respect to any portion of such award the vesting of which remained subject to achievement of performance objectives as of October 4, 2023, $23.95 for each Issuer share underlying the portion of the award that would vest as a result of the Merger in accordance with the terms and conditions of the applicable award agreement, which for the units granted in 2020 assumed performance achievement at the "maximum" level; for the units granted in 2021, assumed performance achievement above "target" with partial achievement of the next stock price hurdle; and for the units granted in 2022, assumed performance achievement at 140% of the "target" level. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 295,300 outstanding unvested shares of restricted stock.
F2: Pursuant to the Agreement and Plan of Merger, dated September 5, 2023, by and among the Issuer, Next Holdco Co., LLC ("Next Holdco") and Next Merger Sub, Inc. ("Merger Sub"), the Issuer became a wholly owned subsidiary of Next Holdco upon consummation of the merger with Merger Sub on November 9, 2023 (the "Effective Time"). At the Effective Time: (a) each of the Issuer's outstanding shares of common stock, each outstanding restricted stock unit and each outstanding deferred stock unit was cancelled and automatically converted into the right to receive $23.95 in cash; (b) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was cancelled and converted into the right to receive $23.95 in cash less the applicable per share exercise price; and (c) each of the Issuer's outstanding performance stock units was cancelled and converted into the right to receive $23.95
F3: (Continued from footnote 2) (with respect to the Issuer shares underlying the portion of such award which had vested), and, with respect to any portion of such award the vesting of which remained subject to achievement of performance objectives as of October 4, 2023, $23.95 for each Issuer share underlying the portion of the award that would vest as a result of the Merger in accordance with the terms and conditions of the applicable award agreement, which for the units granted in 2020 assumed performance achievement at the "maximum" level; for the units granted in 2021, assumed performance achievement above "target" with partial achievement of the next stock price hurdle; and for the units granted in 2022, assumed performance achievement at 140% of the "target" level.
STREAMLINE HEALTH SOLUTIONS INC.
Report date June 17, 2019 · Filed June 19, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.01 par valueSEC Table I · non-derivative | IndirectOwned in trust controlled by and for the benefit of the reporting person | 392,223 |
Reported balance
After 2019-06-17 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2019-06-17 · Sale · Disposed 51,095 · Balance 392,223 |
| Common Stock, $0.01 par valueSEC Table I · non-derivative | IndirectOwned in trust controlled by and for the benefit of the reporting person | 391,551 |
Reported balance
After 2019-06-18 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2019-06-18 · Sale · Disposed 672 · Balance 391,551 |
| Common Stock, $0.01 par valueSEC Table I · non-derivative | IndirectOwned in trust controlled by and for the benefit of the reporting person | 380,000 |
Reported balance
After 2019-06-19 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2019-06-19 · Sale · Disposed 11,551 · Balance 380,000 F1: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.70 to $1.71, inclusive. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. |
| Common Stock, $0.01 par valueSEC Table I · non-derivative | IndirectOwned in Individual Retirement Account | 189,796 |
Reported balance
After 2019-06-19 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2019-06-19 · Sale · Disposed 16,204 · Balance 189,796 F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.70 to $1.705, inclusive. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. |
| Common Stock, $0.01 par valueSEC Table I · non-derivative | Direct | 225,000 |
Reported balance
Holding disclosure · report date 2019-06-17 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 225,000 |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.70 to $1.71, inclusive. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.70 to $1.705, inclusive. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
Teladoc Health, Inc.
Report date July 29, 2021 · Filed August 02, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 11,031 |
Ending reported balance
After 2021-07-30 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2021-07-29 · Exercise / conversion · Acquired 7,299 · Balance 14,451 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Row 2 · 2021-07-30 · Sale · Disposed 3,420 · Balance 11,031 F3: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 7,299 |
Reported balance
After 2021-07-29 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-07-29 · Exercise / conversion · Disposed 7,299 · Balance 7,299 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F2: On July 30, 2019, the reporting person was granted 21,897 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2: On July 30, 2019, the reporting person was granted 21,897 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.
F3: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 09, 2023 Filed Nov 13, 2023 16:37 UTC | NEXTGEN HEALTHCARE, INC. NXGN · Entity 108396 | Disposition to issuerPerformance Stock Units · Derivative | 381,059 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-23-063054 · ownership.xml · derivative · entry 2 Sides David William · CIK 0001619248 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 381,059 shares Expires not disclosed F2 · derivative.exercise_price: Pursuant to the Agreement and Plan of Merger, dated September 5, 2023, by and among the Issuer, Next Holdco Co., LLC ("Next Holdco") and Next Merger Sub, Inc. ("Merger Sub"), the Issuer became a wholly owned subsidiary of Next Holdco upon consummation of the merger with Merger Sub on November 9, 2023 (the "Effective Time"). At the Effective Time: (a) each of the Issuer's outstanding shares of common stock, each outstanding restricted stock unit and each outstanding deferred stock unit was cancelled and automatically converted into the right to receive $23.95 in cash; (b) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was cancelled and converted into the right to receive $23.95 in cash less the applicable per share exercise price; and (c) each of the Issuer's outstanding performance stock units was cancelled and converted into the right to receive $23.95 F3 · derivative.exercise_price: (Continued from footnote 2) (with respect to the Issuer shares underlying the portion of such award which had vested), and, with respect to any portion of such award the vesting of which remained subject to achievement of performance objectives as of October 4, 2023, $23.95 for each Issuer share underlying the portion of the award that would vest as a result of the Merger in accordance with the terms and conditions of the applicable award agreement, which for the units granted in 2020 assumed performance achievement at the "maximum" level; for the units granted in 2021, assumed performance achievement above "target" with partial achievement of the next stock price hurdle; and for the units granted in 2022, assumed performance achievement at 140% of the "target" level. F2 · price: Pursuant to the Agreement and Plan of Merger, dated September 5, 2023, by and among the Issuer, Next Holdco Co., LLC ("Next Holdco") and Next Merger Sub, Inc. ("Merger Sub"), the Issuer became a wholly owned subsidiary of Next Holdco upon consummation of the merger with Merger Sub on November 9, 2023 (the "Effective Time"). At the Effective Time: (a) each of the Issuer's outstanding shares of common stock, each outstanding restricted stock unit and each outstanding deferred stock unit was cancelled and automatically converted into the right to receive $23.95 in cash; (b) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was cancelled and converted into the right to receive $23.95 in cash less the applicable per share exercise price; and (c) each of the Issuer's outstanding performance stock units was cancelled and converted into the right to receive $23.95 F3 · price: (Continued from footnote 2) (with respect to the Issuer shares underlying the portion of such award which had vested), and, with respect to any portion of such award the vesting of which remained subject to achievement of performance objectives as of October 4, 2023, $23.95 for each Issuer share underlying the portion of the award that would vest as a result of the Merger in accordance with the terms and conditions of the applicable award agreement, which for the units granted in 2020 assumed performance achievement at the "maximum" level; for the units granted in 2021, assumed performance achievement above "target" with partial achievement of the next stock price hurdle; and for the units granted in 2022, assumed performance achievement at 140% of the "target" level. F2 · derivative.exercise_date: Pursuant to the Agreement and Plan of Merger, dated September 5, 2023, by and among the Issuer, Next Holdco Co., LLC ("Next Holdco") and Next Merger Sub, Inc. ("Merger Sub"), the Issuer became a wholly owned subsidiary of Next Holdco upon consummation of the merger with Merger Sub on November 9, 2023 (the "Effective Time"). At the Effective Time: (a) each of the Issuer's outstanding shares of common stock, each outstanding restricted stock unit and each outstanding deferred stock unit was cancelled and automatically converted into the right to receive $23.95 in cash; (b) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was cancelled and converted into the right to receive $23.95 in cash less the applicable per share exercise price; and (c) each of the Issuer's outstanding performance stock units was cancelled and converted into the right to receive $23.95 F3 · derivative.exercise_date: (Continued from footnote 2) (with respect to the Issuer shares underlying the portion of such award which had vested), and, with respect to any portion of such award the vesting of which remained subject to achievement of performance objectives as of October 4, 2023, $23.95 for each Issuer share underlying the portion of the award that would vest as a result of the Merger in accordance with the terms and conditions of the applicable award agreement, which for the units granted in 2020 assumed performance achievement at the "maximum" level; for the units granted in 2021, assumed performance achievement above "target" with partial achievement of the next stock price hurdle; and for the units granted in 2022, assumed performance achievement at 140% of the "target" level. F2 · derivative.expiration_date: Pursuant to the Agreement and Plan of Merger, dated September 5, 2023, by and among the Issuer, Next Holdco Co., LLC ("Next Holdco") and Next Merger Sub, Inc. ("Merger Sub"), the Issuer became a wholly owned subsidiary of Next Holdco upon consummation of the merger with Merger Sub on November 9, 2023 (the "Effective Time"). At the Effective Time: (a) each of the Issuer's outstanding shares of common stock, each outstanding restricted stock unit and each outstanding deferred stock unit was cancelled and automatically converted into the right to receive $23.95 in cash; (b) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was cancelled and converted into the right to receive $23.95 in cash less the applicable per share exercise price; and (c) each of the Issuer's outstanding performance stock units was cancelled and converted into the right to receive $23.95 F3 · derivative.expiration_date: (Continued from footnote 2) (with respect to the Issuer shares underlying the portion of such award which had vested), and, with respect to any portion of such award the vesting of which remained subject to achievement of performance objectives as of October 4, 2023, $23.95 for each Issuer share underlying the portion of the award that would vest as a result of the Merger in accordance with the terms and conditions of the applicable award agreement, which for the units granted in 2020 assumed performance achievement at the "maximum" level; for the units granted in 2021, assumed performance achievement above "target" with partial achievement of the next stock price hurdle; and for the units granted in 2022, assumed performance achievement at 140% of the "target" level. Read SEC document |
| November 09, 2023 Filed Nov 13, 2023 16:37 UTC | NEXTGEN HEALTHCARE, INC. NXGN · Entity 108396 | Disposition to issuerCommon Stock | 605,540 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-23-063054 · ownership.xml · nonDerivative · entry 1 Sides David William · CIK 0001619248 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · shares: Includes 295,300 outstanding unvested shares of restricted stock. F2 · price: Pursuant to the Agreement and Plan of Merger, dated September 5, 2023, by and among the Issuer, Next Holdco Co., LLC ("Next Holdco") and Next Merger Sub, Inc. ("Merger Sub"), the Issuer became a wholly owned subsidiary of Next Holdco upon consummation of the merger with Merger Sub on November 9, 2023 (the "Effective Time"). At the Effective Time: (a) each of the Issuer's outstanding shares of common stock, each outstanding restricted stock unit and each outstanding deferred stock unit was cancelled and automatically converted into the right to receive $23.95 in cash; (b) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was cancelled and converted into the right to receive $23.95 in cash less the applicable per share exercise price; and (c) each of the Issuer's outstanding performance stock units was cancelled and converted into the right to receive $23.95 F3 · price: (Continued from footnote 2) (with respect to the Issuer shares underlying the portion of such award which had vested), and, with respect to any portion of such award the vesting of which remained subject to achievement of performance objectives as of October 4, 2023, $23.95 for each Issuer share underlying the portion of the award that would vest as a result of the Merger in accordance with the terms and conditions of the applicable award agreement, which for the units granted in 2020 assumed performance achievement at the "maximum" level; for the units granted in 2021, assumed performance achievement above "target" with partial achievement of the next stock price hurdle; and for the units granted in 2022, assumed performance achievement at 140% of the "target" level. Read SEC document |
| November 07, 2023 Filed Nov 13, 2023 16:32 UTC | NEXTGEN HEALTHCARE, INC. NXGN · Entity 108396 | GiftCommon Stock | 6,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-063039 · ownership.xml · nonDerivative · entry 1 Sides David William · CIK 0001619248 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 605,540 F1 · kind: This transaction was a charitable gift of securities by the reporting person. Read SEC document |
| October 30, 2023 Filed Nov 1, 2023 17:22 UTC | NEXTGEN HEALTHCARE, INC. NXGN · Entity 108396 | Tax withholdingCommon Stock | 18,931 | $23.89 | $452,261.59 |
DisclosureSEC source: 0001209191-23-054040 · doc4.xml · nonDerivative · entry 1 Sides David William · CIK 0001619248 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 612,040 F1 · kind: Represents shares withheld to satisfy tax withholding obligations on the vesting of restricted stock. Read SEC document |
| September 22, 2023 Filed Sep 25, 2023 17:05 UTC | NEXTGEN HEALTHCARE, INC. NXGN · Entity 108396 | Exercise / conversionPerformance Stock Units · Derivative | 24,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-050496 · doc4.xml · derivative · entry 4 Sides David William · CIK 0001619248 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,333 Underlying: Common Stock · 24,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert to shares of NXGN common stock on a one-for-one basis once fully vested. F4 · derivative.exercise_date: The reporting person was granted performance stock units that vest upon both the attainment of four separate pre-determined stock price milestones and continued service over a period of three years commencing September 22, 2021. 73,000 of these performance stock units were tied to a stock price milestone of $19.38, which was met in April 2022. As of September 22, 2023, 2/3 of the performance stock units tied to the $19.38 stock price milestone are fully vested. The remaining 24,333 performance stock units tied to the $19.38 stock price milestone will vest on September 22, 2024. F4 · derivative.expiration_date: The reporting person was granted performance stock units that vest upon both the attainment of four separate pre-determined stock price milestones and continued service over a period of three years commencing September 22, 2021. 73,000 of these performance stock units were tied to a stock price milestone of $19.38, which was met in April 2022. As of September 22, 2023, 2/3 of the performance stock units tied to the $19.38 stock price milestone are fully vested. The remaining 24,333 performance stock units tied to the $19.38 stock price milestone will vest on September 22, 2024. Read SEC document |
| September 22, 2023 Filed Sep 25, 2023 17:05 UTC | NEXTGEN HEALTHCARE, INC. NXGN · Entity 108396 | Tax withholdingCommon Stock | 98,820 | $23.65 | $2,337,093.00 |
DisclosureSEC source: 0001209191-23-050496 · doc4.xml · nonDerivative · entry 3 Sides David William · CIK 0001619248 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 630,971 F3 · kind: Represents shares withheld to satisfy tax withholding obligations on the vesting of restricted stock. Read SEC document |
| September 22, 2023 Filed Sep 25, 2023 17:05 UTC | NEXTGEN HEALTHCARE, INC. NXGN · Entity 108396 | Tax withholdingCommon Stock | 8,419 | $23.65 | $199,109.35 |
DisclosureSEC source: 0001209191-23-050496 · doc4.xml · nonDerivative · entry 2 Sides David William · CIK 0001619248 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 729,791 F2 · kind: Represents shares withheld to satisfy tax withholding obligations on the vesting of performance stock units. Read SEC document |
| September 22, 2023 Filed Sep 25, 2023 17:05 UTC | NEXTGEN HEALTHCARE, INC. NXGN · Entity 108396 | Exercise / conversionCommon Stock | 24,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-050496 · doc4.xml · nonDerivative · entry 1 Sides David William · CIK 0001619248 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 738,210 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance stock units convert to shares of NXGN common stock on a one-for-one basis once fully vested. Read SEC document |
| October 28, 2022 Filed Nov 1, 2022 19:39 UTC | NEXTGEN HEALTHCARE, INC. NXGN · Entity 108396 | GrantPerformance Stock Units · Derivative | 184,049 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-055155 · doc4.xml · derivative · entry 2 Sides David William · CIK 0001619248 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 609,715 Underlying: Common Stock · 184,049 shares Expires not disclosed F2 · derivative.exercise_price: On October 28, 2022, the reporting person was granted certain performance stock units that are subject to both performance and time based vesting requirements. The number of PSUs reported represents the target number of PSUs. The number of PSUs that vest, if any, may vary from 0% to 210% of the target number reported. F2 · derivative.exercise_date: On October 28, 2022, the reporting person was granted certain performance stock units that are subject to both performance and time based vesting requirements. The number of PSUs reported represents the target number of PSUs. The number of PSUs that vest, if any, may vary from 0% to 210% of the target number reported. F2 · derivative.expiration_date: On October 28, 2022, the reporting person was granted certain performance stock units that are subject to both performance and time based vesting requirements. The number of PSUs reported represents the target number of PSUs. The number of PSUs that vest, if any, may vary from 0% to 210% of the target number reported. Read SEC document |
| October 28, 2022 Filed Nov 1, 2022 19:39 UTC | NEXTGEN HEALTHCARE, INC. NXGN · Entity 108396 | GrantCommon Stock | 122,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-055155 · doc4.xml · nonDerivative · entry 1 Sides David William · CIK 0001619248 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 712,532 F1 · shares: The shares of restricted stock vest in annual increments as follows: 1/3 vest on November 1, 2023, 1/3 vest on November 1, 2024, and 1/3 vest on November 1, 2025, subject to continued service through each vesting date. Read SEC document |
| September 22, 2022 Filed Sep 26, 2022 17:40 UTC | NEXTGEN HEALTHCARE, INC. NXGN · Entity 108396 | Exercise / conversionPerformance Stock Units · Derivative | 24,334 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-051283 · doc4.xml · derivative · entry 4 Sides David William · CIK 0001619248 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 425,666 Underlying: Common Stock · 24,334 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert to shares of NXGN common stock on a one-for-one basis once fully vested. F4 · derivative.exercise_date: The reporting person was granted performance stock units that vest upon both the attainment of four separate pre-determined stock price milestones and continued service over a period of three years commencing September 22, 2021. 73,000 of these performance stock units were tied to a stock price milestone of $19.38, which was met in April 2022. As of September 22, 2022, 1/3 of the performance stock units tied to the $19.38 stock price milestone are fully vested. The remaining 48,666 performance stock units tied to the $19.38 stock price milestone will vest in equal installments on September 22, 2023 and September 22, 2024. F4 · derivative.expiration_date: The reporting person was granted performance stock units that vest upon both the attainment of four separate pre-determined stock price milestones and continued service over a period of three years commencing September 22, 2021. 73,000 of these performance stock units were tied to a stock price milestone of $19.38, which was met in April 2022. As of September 22, 2022, 1/3 of the performance stock units tied to the $19.38 stock price milestone are fully vested. The remaining 48,666 performance stock units tied to the $19.38 stock price milestone will vest in equal installments on September 22, 2023 and September 22, 2024. Read SEC document |
| September 22, 2022 Filed Sep 26, 2022 17:40 UTC | NEXTGEN HEALTHCARE, INC. NXGN · Entity 108396 | Tax withholdingCommon Stock | 72,627 | $17.02 | $1,236,111.54 |
DisclosureSEC source: 0001209191-22-051283 · doc4.xml · nonDerivative · entry 3 Sides David William · CIK 0001619248 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 589,832 F3 · kind: Represents shares withheld to satisfy tax withholding obligations on the vesting of restricted stock. Read SEC document |
| September 22, 2022 Filed Sep 26, 2022 17:40 UTC | NEXTGEN HEALTHCARE, INC. NXGN · Entity 108396 | Tax withholdingCommon Stock | 11,256 | $17.02 | $191,577.12 |
DisclosureSEC source: 0001209191-22-051283 · doc4.xml · nonDerivative · entry 2 Sides David William · CIK 0001619248 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 662,459 F2 · kind: Represents shares withheld to satisfy tax withholding obligations on the vesting of performance stock units. Read SEC document |
| September 22, 2022 Filed Sep 26, 2022 17:40 UTC | NEXTGEN HEALTHCARE, INC. NXGN · Entity 108396 | Exercise / conversionCommon Stock | 24,334 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-051283 · doc4.xml · nonDerivative · entry 1 Sides David William · CIK 0001619248 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 673,715 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance stock units convert to shares of NXGN common stock on a one-for-one basis once fully vested. Read SEC document |
| November 30, 2021 Filed Nov 30, 2021 17:55 UTC | NEXTGEN HEALTHCARE, INC. NXGN · Entity 108396 | PurchaseCommon Stock | 6,500 | $15.62 | $101,499.45 |
DisclosureSEC source: 0001209191-21-067174 · doc4.xml · nonDerivative · entry 1 Sides David William · CIK 0001619248 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 647,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.61 to $15.63. Full information regarding the number of shares purchased at each separate price will be provided to the SEC, the issuer or its stockholders upon request. Read SEC document |
| September 22, 2021 Filed Sep 24, 2021 16:38 UTC | NEXTGEN HEALTHCARE, INC. NXGN · Entity 108396 | GrantPerformance Stock Units · Derivative | 450,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-057619 · doc4.xml · derivative · entry 3 Sides David William · CIK 0001619248 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,000 Underlying: Common Stock · 450,000 shares Expires not disclosed F2 · derivative.exercise_price: The performance stock unit awards vest upon both the attainment of five separate pre-determined stock price milestones and continued service over a period of three years following the grant date. F2 · derivative.exercise_date: The performance stock unit awards vest upon both the attainment of five separate pre-determined stock price milestones and continued service over a period of three years following the grant date. F2 · derivative.expiration_date: The performance stock unit awards vest upon both the attainment of five separate pre-determined stock price milestones and continued service over a period of three years following the grant date. Read SEC document |
| September 22, 2021 Filed Sep 24, 2021 16:38 UTC | NEXTGEN HEALTHCARE, INC. NXGN · Entity 108396 | GrantCommon Stock | 471,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-057619 · doc4.xml · nonDerivative · entry 2 Sides David William · CIK 0001619248 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 640,500 F1 · shares: The shares of restricted stock vest over three years in annual increments as follows: 1/3 vest on the first anniversary of the date of grant, 1/3 vest on the second anniversary of the date of grant, and 1/3 vest on the third anniversary of the date of grant, subject to continued service through each vesting date. Read SEC document |
| September 22, 2021 Filed Sep 24, 2021 16:38 UTC | NEXTGEN HEALTHCARE, INC. NXGN · Entity 108396 | GrantCommon Stock | 169,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-057619 · doc4.xml · nonDerivative · entry 1 Sides David William · CIK 0001619248 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,500 F1 · shares: The shares of restricted stock vest over three years in annual increments as follows: 1/3 vest on the first anniversary of the date of grant, 1/3 vest on the second anniversary of the date of grant, and 1/3 vest on the third anniversary of the date of grant, subject to continued service through each vesting date. Read SEC document |
| July 30, 2021 Filed Aug 2, 2021 20:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 3,420 | $154.38 | $527,965.92 |
DisclosureSEC source: 0001179110-21-007808 · edgar.xml · nonDerivative · entry 2 Sides David William · CIK 0001619248 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,031 F3 · shares: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award. Read SEC document |
| July 29, 2021 Filed Aug 2, 2021 20:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 7,299 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-007808 · edgar.xml · derivative · entry 3 Sides David William · CIK 0001619248 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,299 Underlying: Common Stock · 7,299 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F2 · derivative.exercise_date: On July 30, 2019, the reporting person was granted 21,897 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. F2 · derivative.expiration_date: On July 30, 2019, the reporting person was granted 21,897 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| July 29, 2021 Filed Aug 2, 2021 20:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 7,299 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-21-007808 · edgar.xml · nonDerivative · entry 1 Sides David William · CIK 0001619248 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,451 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 22:21 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,866 | $206.99 | $593,233.34 |
DisclosureSEC source: 0001179110-21-002982 · edgar.xml · nonDerivative · entry 1 Sides David William · CIK 0001619248 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,152 F1 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit and performance stock unit awards. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 00:48 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 7,457 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002805 · edgar.xml · derivative · entry 6 Sides David William · CIK 0001619248 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,457 Underlying: Common Stock · 7,457 shares Expires not disclosed F8 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F9 · derivative.exercise_date: The restricted stock units vest in three substantially equal annual installments beginning on the first anniversary of the grant date. F9 · derivative.expiration_date: The restricted stock units vest in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 00:48 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 4,552 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002805 · edgar.xml · derivative · entry 5 Sides David William · CIK 0001619248 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,104 Underlying: Common Stock · 4,552 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F7 · derivative.exercise_date: On March 2, 2021, the reporting person earned 13,656 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021. F7 · derivative.expiration_date: On March 2, 2021, the reporting person earned 13,656 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 00:48 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantPerformance Stock Units · Derivative | 13,656 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002805 · edgar.xml · derivative · entry 4 Sides David William · CIK 0001619248 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,656 Underlying: Common Stock · 13,656 shares Expires not disclosed F4 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of TDOC common stock. F5 · shares: Performance award amount determined based on metrics in respect of the issuer's 2020 financial results. F6 · derivative.exercise_date: The performance stock units vest in three substantially equal annual installments beginning on March 2, 2021. F6 · derivative.expiration_date: The performance stock units vest in three substantially equal annual installments beginning on March 2, 2021. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 00:48 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 2,678 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002805 · edgar.xml · derivative · entry 3 Sides David William · CIK 0001619248 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,355 Underlying: Common Stock · 2,678 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On March 2, 2020, the reporting person was granted 8,033 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On March 2, 2020, the reporting person was granted 8,033 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 00:48 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 4,552 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-21-002805 · edgar.xml · nonDerivative · entry 2 Sides David William · CIK 0001619248 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,018 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 00:48 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,678 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-21-002805 · edgar.xml · nonDerivative · entry 1 Sides David William · CIK 0001619248 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,466 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 20:07 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,084 | $0.00 Strike: $68.50 | $0.00 |
DisclosureSEC source: 0001179110-20-008828 · edgar.xml · derivative · entry 3 Sides David William · CIK 0001619248 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,424 Underlying: Common Stock · 4,084 shares Expires 2029-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the shares on July 30, 2020. The remainder of the shares will vest in 36 equal monthly installments thereafter. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 20:07 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 5,478 | $216.00 | $1,183,248.00 |
DisclosureSEC source: 0001179110-20-008828 · edgar.xml · nonDerivative · entry 2 Sides David William · CIK 0001619248 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,788 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 10, 2020. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 20:07 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 4,084 | $68.50 | $279,754.00 |
DisclosureSEC source: 0001179110-20-008828 · edgar.xml · nonDerivative · entry 1 Sides David William · CIK 0001619248 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,266 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 30, 2020 Filed Jul 31, 2020 20:07 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 7,299 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-008611 · edgar.xml · derivative · entry 3 Sides David William · CIK 0001619248 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,598 Underlying: Common Stock · 7,299 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F4 · derivative.exercise_date: On July 30, 2019, the reporting person was granted 21,897 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On July 30, 2019, the reporting person was granted 21,897 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| July 30, 2020 Filed Jul 31, 2020 20:07 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 3,117 | $216.67 | $675,360.39 |
DisclosureSEC source: 0001179110-20-008611 · edgar.xml · nonDerivative · entry 2 Sides David William · CIK 0001619248 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,182 F2 · shares: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award. Read SEC document |
| July 30, 2020 Filed Jul 31, 2020 20:07 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 7,299 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-20-008611 · edgar.xml · nonDerivative · entry 1 Sides David William · CIK 0001619248 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,299 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:17 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 8,033 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-003062 · edgar.xml · derivative · entry 1 Sides David William · CIK 0001619248 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,033 Underlying: Common Stock · 8,033 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning March 2, 2021. F2 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning March 2, 2021. Read SEC document |
| June 19, 2019 Filed Jun 19, 2019 20:40 UTC | STREAMLINE HEALTH SOLUTIONS INC. STRM · Entity 76542 | SaleCommon Stock, $0.01 par value | 16,204 | $1.70 | $27,546.80 |
DisclosureSEC source: 0001104659-19-036476 · a4.xml · nonDerivative · entry 4 Sides David William · CIK 0001619248 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Owned in Individual Retirement Account Disclosed balance after: 189,796 F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.70 to $1.705, inclusive. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| June 19, 2019 Filed Jun 19, 2019 20:40 UTC | STREAMLINE HEALTH SOLUTIONS INC. STRM · Entity 76542 | SaleCommon Stock, $0.01 par value | 11,551 | $1.70 | $19,636.70 |
DisclosureSEC source: 0001104659-19-036476 · a4.xml · nonDerivative · entry 3 Sides David William · CIK 0001619248 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Owned in trust controlled by and for the benefit of the reporting person Disclosed balance after: 380,000 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.70 to $1.71, inclusive. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| June 18, 2019 Filed Jun 19, 2019 20:40 UTC | STREAMLINE HEALTH SOLUTIONS INC. STRM · Entity 76542 | SaleCommon Stock, $0.01 par value | 672 | $1.71 | $1,149.12 |
DisclosureSEC source: 0001104659-19-036476 · a4.xml · nonDerivative · entry 2 Sides David William · CIK 0001619248 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Owned in trust controlled by and for the benefit of the reporting person Disclosed balance after: 391,551 Read SEC document |
| June 17, 2019 Filed Jun 19, 2019 20:40 UTC | STREAMLINE HEALTH SOLUTIONS INC. STRM · Entity 76542 | SaleCommon Stock, $0.01 par value | 51,095 | $1.77 | $90,438.15 |
DisclosureSEC source: 0001104659-19-036476 · a4.xml · nonDerivative · entry 1 Sides David William · CIK 0001619248 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Owned in trust controlled by and for the benefit of the reporting person Disclosed balance after: 392,223 Read SEC document |
| January 29, 2019 Filed Jan 30, 2019 16:45 UTC | STREAMLINE HEALTH SOLUTIONS INC. STRM · Entity 76542 | GrantCommon Stock, $0.01 par value | 225,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-006018 · doc4.xml · nonDerivative · entry 1 Sides David William · CIK 0001619248 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,000 F1 · kind: Grant of restricted stock, which will vest, assuming continued employment, in equal installments on each of the first three anniversaries of the date of the grant. Read SEC document |
| January 09, 2019 Filed Jan 10, 2019 17:35 UTC | STREAMLINE HEALTH SOLUTIONS INC. STRM · Entity 76542 | PurchaseCommon Stock, $0.01 par value | 10,000 | $0.98 | $9,800.00 |
DisclosureSEC source: 0001209191-19-003299 · doc4.xml · nonDerivative · entry 2 Sides David William · CIK 0001619248 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Owned in Individual Retirement Account Disclosed balance after: 206,000 Read SEC document |
| January 09, 2019 Filed Jan 11, 2019 15:53 UTC Amendment | STREAMLINE HEALTH SOLUTIONS INC. STRM · Entity 76542 | PurchaseCommon Stock, $0.01 par value | 10,000 | $0.98 | $9,800.00 |
DisclosureSEC source: 0001209191-19-003401 · doc4a.xml · nonDerivative · entry 2 Sides David William · CIK 0001619248 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Owned in Individual Retirement Account Disclosed balance after: 206,000 Read SEC document |
| January 08, 2019 Filed Jan 10, 2019 17:35 UTC | STREAMLINE HEALTH SOLUTIONS INC. STRM · Entity 76542 | PurchaseCommon Stock, $0.01 par value | 10,000 | $0.94 | $9,400.00 |
DisclosureSEC source: 0001209191-19-003299 · doc4.xml · nonDerivative · entry 1 Sides David William · CIK 0001619248 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Owned in Individual Retirement Account Disclosed balance after: 196,000 Read SEC document |
| January 08, 2019 Filed Jan 11, 2019 15:53 UTC Amendment | STREAMLINE HEALTH SOLUTIONS INC. STRM · Entity 76542 | PurchaseCommon Stock, $0.01 par value | 10,000 | $0.94 | $9,400.00 |
DisclosureSEC source: 0001209191-19-003401 · doc4a.xml · nonDerivative · entry 1 Sides David William · CIK 0001619248 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Owned in Individual Retirement Account Disclosed balance after: 196,000 Read SEC document |
| April 13, 2017 Filed Apr 14, 2017 16:26 UTC | STREAMLINE HEALTH SOLUTIONS INC. STRM · Entity 76542 | PurchaseCommon Stock, $0.01 par value | 5,000 | $1.30 | $6,500.00 |
DisclosureSEC source: 0001209191-17-026986 · doc4.xml · nonDerivative · entry 1 Sides David William · CIK 0001619248 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Owned in Individual Retirement Account Disclosed balance after: 186,000 F1 · price: This transaction was executed in multiple trades at prices ranging from $1.26 to $1.33. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| March 02, 2017 Filed Mar 6, 2017 17:17 UTC | STREAMLINE HEALTH SOLUTIONS INC. STRM · Entity 76542 | GrantStock Option · Derivative | 100,000 | $0.00 Strike: $1.18 | $0.00 |
DisclosureSEC source: 0001209191-17-018405 · doc4.xml · derivative · entry 4 Sides David William · CIK 0001619248 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock, $0.01 par value · 100,000 shares Expires 2027-03-01 F2 · derivative.exercise_date: The stock options shall vest and become exercisable in thirty-six substantially equal monthly installments commencing on March 2, 2017, subject to the reporting person's continued employment over such thirty-six month period. Read SEC document |
| December 12, 2016 Filed Dec 14, 2016 13:17 UTC | STREAMLINE HEALTH SOLUTIONS INC. STRM · Entity 76542 | PurchaseCommon Stock, $0.01 par value | 10,000 | $1.36 | $13,599.00 |
DisclosureSEC source: 0001209191-16-155086 · doc4.xml · nonDerivative · entry 1 Sides David William · CIK 0001619248 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Owned in Individual Retirement Account Disclosed balance after: 181,000 Read SEC document |
| September 16, 2016 Filed Sep 19, 2016 15:31 UTC | STREAMLINE HEALTH SOLUTIONS INC. STRM · Entity 76542 | PurchaseCommon Stock, $0.01 par value | 1,000 | $1.63 | $1,630.00 |
DisclosureSEC source: 0001209191-16-141958 · doc4.xml · nonDerivative · entry 1 Sides David William · CIK 0001619248 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Owned in Individual Retirement Account Disclosed balance after: 171,000 F1 · price: This transaction was executed in multiple trades at prices ranging from $1.59 to $1.64. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.